New shot aims to tame bleeding disorder in small trial
NCT ID NCT07640893
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests an injection called SR604 in 24 adults with von Willebrand disease, a bleeding disorder. The goal is to see if it safely reduces the number of bleeding episodes. Participants receive multiple doses, and researchers track bleeding rates and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SR604 injection
- What this could lead to
- If successful, this could provide a new treatment option to control bleeding episodes in people with von Willebrand disease.
- What could go wrong
- This is an early Phase 2 trial with only 24 participants, so results may not apply to everyone. The treatment may not reduce bleeding as hoped or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, China
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, China
-
Jinan Central Hospital
RECRUITINGJinan, China
-
North China University of Science and Technology Affiliated Hospital
RECRUITINGTangshan, China
-
The First Affiliated Hospital of Guangxi Medical University
RECRUITINGNanning, China
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, China
-
The First Affiliated Hospital of University of Science and Technology of China
RECRUITINGHefei, China
-
The Second Hospital of Shanxi Medical University
RECRUITINGTaiyuan, China
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New algorithm aims to stop dangerous bleeding in VWD patients
- Family history questions may improve bleeding disorder detection in kids
- New drug aims to lighten heavy periods for bleeding disorder patients
- UK doctors look back at real-world use of new VWD drug
- New study tracks bleeding drug in kids
- New study aims to uncover hidden bleeding disorder in egyptian kids